» Articles » PMID: 19907906

Re-evaluation of Animal Numbers and Costs for in Vivo Tests to Accomplish REACH Legislation Requirements for Chemicals - a Report by the Transatlantic Think Tank for Toxicology (t(4))

Overview
Journal ALTEX
Date 2009 Nov 13
PMID 19907906
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

The EU REACH legislation for chemicals of 2006 represents the largest investment into consumer product safety ever. A reanalysis of cost and animal use estimates was carried out based on the final legislation, test guidance for industry published by the European Chemical Agency, and the preregistration completed in December 2008. The new estimates for the number of substances falling under REACH range from 68 to 101,000 chemicals, substantially exceeding the earlier estimates of 29,000 substances. The latter estimates were, however, based on data before 1994 and both expansion of the EU and growth of the chemical industry since have contributed to higher numbers today. The lower estimate of 68,000 chemicals was carried through current testing requirements with due regard to emerging alternative approaches, using in all cases the most optimistic assumptions (minimal animal numbers per test and neglecting most triggering of additional tests and confirmatory (re-)tests as well as tests requested but not yet defined for endocrine disruption, respiratory irritation, respiratory sensitization and developmental neurotoxicity). The most demanding studies are in the area of reproductive toxicity testing with about 90% of all animal use and 70% of the required costs for registration. The overall result suggests a demand of 54 million vertebrate animals and testing costs of 9.5 billion euro. This clearly challenges the feasibility of the program without a major investment into high-throughput methodologies.

Citing Articles

Toxicity of ACP-105: a substance used as doping in sports: application of in silico methods for prediction of selected toxicological endpoints.

Fijalkowska O, Jurowski K Arch Toxicol. 2025; .

PMID: 40064700 DOI: 10.1007/s00204-025-03962-z.


Development of hybrid models by the integration of the read-across hypothesis with the QSAR framework for the assessment of developmental and reproductive toxicity (DART) tested according to OECD TG 414.

Pandey S, Roy K Toxicol Rep. 2024; 13:101822.

PMID: 39649380 PMC: 11621937. DOI: 10.1016/j.toxrep.2024.101822.


Organoid intelligence for developmental neurotoxicity testing.

Alam El Din D, Shin J, Lysinger A, Roos M, Johnson E, Shafer T Front Cell Neurosci. 2024; 18:1480845.

PMID: 39440004 PMC: 11493634. DOI: 10.3389/fncel.2024.1480845.


Standardization and optimization of the hiPSC-based PluriLum assay for detection of embryonic and developmental toxicants.

Treschow A, Vinggaard A, Valente M Arch Toxicol. 2024; 98(12):4107-4116.

PMID: 39365317 PMC: 11496362. DOI: 10.1007/s00204-024-03870-8.


Yeast-Based Screening of Anti-Viral Molecules.

Srivastava V, Kumar R, Ahmad A Microorganisms. 2024; 12(3).

PMID: 38543629 PMC: 10974075. DOI: 10.3390/microorganisms12030578.